Human papillomaviruses (HPV) are associated with multiple myeloma

International Journal of Oncology

Volumn 9, Issue 2, 1996, Pages 345-349

  Payne, Deborah A ^a   Tyring, Stephen K ^a   Kumar, S ^a   Patten, B M ^b   Shoaib, B Ostermeyer ^b   Chan, T S ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow; HPV; Lymphocytes; Multiple myeloma

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 0030036473     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.2.345     Document Type: Article

References (20)

1. Bataille R, Klein B and Rossi J: Immunology of myeloma. Nouv Rev Fr Hematol 29: 255-264, 1987.
2. Greipp P: Monoclonal gammopathies: new approaches to clinical problems in diagnosis and prognosis. Blood Rev 3: 222-236, 1989.
3. Ludwig H: The clinical picture of multiple myeloma. Onkologie 9: 202-206, 1986.
4. Potter M: Prospectives on the origins of multiple myeloma and plasmacytomas in mice. Hematol/Oncol Clin North Amer 6: 211-223, 1992.
5. Payne D, Tyring SK, Doherty MG, Daya D and Chan T-S: Case Report: Detection of human papillomavirus type 16 in plasma cells. Gynecol Oncol 48: 406-412, 1993.
6. Payne D, Chan T-S, Patten B and Tyring SK: Extrachromosomal human papillomavirus (HPV) in multiple myeloma and monoclonal gammopathy of unknown significance (MGUS) patients. Anticancer Res 15: 2213-2216, 1995.
7. Saiki R, Gelfand D, Stoffel S, Scharf S, Higuchi R, Horn G, Mullis K and Erlich H: Primer directed enzymatic amplification of DNA with thermostable DNA polymerase. Science 239: 487-491, 1988.
8. Gregoire L, Arella M, Campione-Piccardo J and Lancaster W: Amplification of human papillomavirus sequences using conserved primers. J Clin Microbiol 27: 2660-2665, 1989.
9. Manos M, Ting Y, Wright D, Lewis A, Broker T and Wolinsky S: Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7: 209-214, 1989.
10. Payne D, Hoskins S, Schouten H, van Vleuten H and Tyring S: Increased buffer pH enhances sensitivity and specificity of human papillomavirus detection using consensus primer based PCR. J Virol Methods 52: 104-110, 1995.
11. Erlich H: PCR Technology. Stockton Press, New York, NY, 1989.
12. Sambrook J, Fritsch E and Maniatus T: Molecular Cloning, A Laboratory Manual. 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
13. Pao C, Lin S, Lin C, Maa J, Lai C and Hsieh T: Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am J Clin Pathol 95: 540-546, 1991.
14. Ostrow R, Zachow K, Weber D, Okagaki T, Fukushima M, Clark B, Twiggs L and Faras A: Presence and possible involvement of HPV DNA in premalignant tumors in papillomaviruses. In: Molecular and Clinical Aspects. P. Howley and T. Broker (eds.) New York, Alan R. Liss, pp101-122, 1985.
15. Durst M, Schwartz E and Gismann L: Integration and persistence of human papillomavirus DNA in genital tumors. In: Viral Etiology of Cervical Cancer. R. Peto, H. zur Hausen, (eds.) pp273-280, 1986.
16. Kedzia H, Gozdzicka-J'ozefiak A, Wolna M and Tomczak E: Distribution of human papillomavirus 16 in the blood of women with uterine cervix carcinoma. Eur J Gynaecol Oncol 13: 522-526, 1992.
17. Kedzia WM, Gozdzicka-J'ozefiak A and Hedzia H: Human papillomavirus 16 in the blood of women treated for cervical cancer. Eur J Gynaecol Oncol 14: 408-411, 1993.
18. Campo MS, Jarrett WF, O'Neil W and Barron RJ: Latent papillomavirus infection in cattle. Res Vet Sci 56: 151-157, 1994.
19. Bonnez W, Reichman RC, Strussenberg J and Roberts NJ Jr: In vitro interactions between bovine papillomavirus and human monocytes and macrophages. Intervirology 32: 246-252, 1991.
20. Lowensohn-Fuchs I, Berke Z, Webster D, Dalianas T and Elfgren K: Human papillomavirus (HPV) DNA is not detected in the peripheral blood cells (PBLs) of patients with cervical carcinoma. Genitourn Med 70: 359-360, 1994.